Associate Professor of Pharmacology, Department of Pharmacology, University of Michigan Medical School,USA
Michael Holinstat received his Ph.D. in Pharmacology from the University of Illinois at Chicago and postdoctoral training at Vanderbilt University. His research focuses on identifying novel approaches to anti-platelet therapy with a special emphasis on regulation of platelets through the lipoxygenase pathway leading to a number of oxidized fatty acids which may play a central role in regulating unwanted platelet activation. Additionally, the lab studies regulation of platelet signaling through PAR1 and PAR4.
Michael Holinstat has research interest in thrombosis, signal transduction, Pharmacology, Hematology.